Canadian Plasma Resources

Last updated
Canadian Plasma Resources
AbbreviationCPR
Formation2012
Type Private
Purpose bio-pharmaceutical production
Headquarters Canada
Location
Key people
Dr. Barzin Bahardoust, CEO
Staff
140
Website www.giveplasma.ca
RemarksProducer of source plasma and plasma proteins

Canadian Plasma Resources (CPR) is a private, for-profit bio-pharmaceutical company and a licensed blood establishment based in Saskatoon, Saskatchewan, Canada. It was founded in 2012 and specializes in the collection of source plasma for further manufacturing and contract-manufacturing of plasma-based bio-pharmaceuticals with operations in Saskatoon (Saskatchewan), Moncton (New Brunswick), Calgary, Edmonton (Alberta), Winnipeg (Manitoba) and administrative office in Oakville, Ontario. CPR is one of the only four establishments in Canada that are licensed to collect plasma. The others are Canadian Blood Services (CBS), Hema-Quebec and Cangene, now owned by ProMetic Life Sciences Inc.

Contents

History

Canadian Plasma Resources is the first private blood establishment company established in Canada for the sole purpose of collecting high quality plasma from healthy donors for further manufacturing. Initially, CPR had planned to base its operation in the Greater Toronto and Hamilton Area. As a result, CPR established two plasma collection centers in Toronto. [1] Both of these centers obtained authorization from the Biologic and Genetic Therapies Directorate of Health Canada and were granted establishment licenses in 2014. Like similar operations in the US and some European countries, CPR provides compensation for the donor's time. [2] This resulted in significant controversy centered around the paid donor model [3] and created a divide in the medical community. [4] [5] At the request of the government of Ontario, [6] Health Canada organized a public consultation [7] and concluded that donor compensation is not a safety concern. Therefore, it will not prohibit donor compensation. [8] In spite of this, in 2014, the government of Ontario introduced legislation specifically to prohibit CPR from operating in Ontario. [9] [10] Several stakeholders including the Canadian Blood Services (CBS) and many patient organizations argued that prohibiting pay-for-plasma would harm patients. [11] [12] [13] However, this did not change the position of the Ontario government. [14] By that time, CPR had already received strong support from several other Canadian provincial governments [15] citing Canada's over-reliance on other countries with paid donor models for procurement of plasma products. In 2015, CPR decided to relocate its operation to Saskatchewan. [16] The company's first facility in Saskatchewan received Health Canada license in early 2016 and was formally opened on February 18, 2016, by Minister Dustin Duncan, Saskatchewan's minister of Health. [17] On July 17, 2017, CPR received Health Canada license for its second facility which opened during the same month in Moncton, New Brunswick. [18] In 2017, Health Canada established an Expert Panel to provide an evidence-based assessment of the sustainability of Canada's immune globulin supply in an increasingly competitive global market, and of the potential impact on the blood supply if private plasma collection expanded significantly in Canada. The final report was published in March 2018. [19] The report concluded that Canada needs to do more to collect plasma and take other steps to enhance self-sufficiency in meeting the needs of its citizens. The panel also found no compelling data to suggest that expansion of source plasma collection – whether with paid or unpaid donors - has negatively impacted the whole blood supply. However, it cautioned that this is an issue which should be further researched, and it requires ongoing oversight and vigilance. [20]

Operations

Canadian Plasma Resources is a source member of the Plasma Protein Therapeutics Association [21] and its facilities are certified through the International Quality Plasma Program. CPR plasma collection facilities are located in Saskatoon and Moncton. Plasma collection is done through automated apheresis. To ensure donor and product safety, each center is operated under the responsibility of a licensed physician, and certain tasks are delegated by the physician to registered nurses. Plasma from these operations can only be used for further manufacturing into therapies such as immunoglobulin, human albumin and blood coagulation factors, which are among the World Health Organization's list of essential medicines. This collected plasma cannot be used for direct transfusion into patients. CPR is licensed by Health Canada for component preparation and testing. Health Canada is considered a leader in blood safety regulations as recognized by the World Health Organization. [22]

Products

Related Research Articles

<span class="mw-page-title-main">Blood plasma</span> Liquid component of blood

Blood plasma is a light amber-colored liquid component of blood in which blood cells are absent, however contains proteins and other constituents of whole blood in suspension. It makes up about 55% of the body's total blood volume. It is the intravascular part of extracellular fluid. It is mostly water, and contains important dissolved proteins, glucose, clotting factors, electrolytes, hormones, carbon dioxide, and oxygen. It plays a vital role in an intravascular osmotic effect that keeps electrolyte concentration balanced and protects the body from infection and other blood-related disorders.

<span class="mw-page-title-main">Blood donation</span> Blood withdrawal for use by another person via transfusion

A blood donation occurs when a person voluntarily has blood drawn and used for transfusions and/or made into biopharmaceutical medications by a process called fractionation. Donation may be of whole blood, or of specific components directly (apheresis). Blood banks often participate in the collection process as well as the procedures that follow it.

<span class="mw-page-title-main">Apheresis</span> Medical techniques to separate one or more components of blood

Apheresis is a medical technology in which the blood of a person is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. It is thus an extracorporeal therapy.

<span class="mw-page-title-main">Plasmapheresis</span> Removal, treatment and return of blood plasma

Plasmapheresis is the removal, treatment, and return or exchange of blood plasma or components thereof from and to the blood circulation. It is thus an extracorporeal therapy, a medical procedure performed outside the body.

<span class="mw-page-title-main">Centre for Addiction and Mental Health</span> Hospital in Ontario, Canada

The Centre for Addiction and Mental Health is a psychiatric teaching hospital located in Toronto and ten community locations throughout the province of Ontario, Canada. It reports being the largest research facility in Canada for mental health and addictions. The hospital was formed in 1998 from the amalgamation of four separate institutions – the Queen Street Mental Health Centre, the Clarke Institute of Psychiatry, the Addiction Research Foundation, and the Donwood Institute. It is Canada's largest mental health teaching hospital, and the only stand-alone psychiatric emergency department in Ontario. CAMH has 90 distinct clinical services across inpatient, outpatient, day treatment, and partial hospitalization models. CAMH has been the site of major advancements in psychiatric research, including the discovery of the Dopamine receptor D2.

<span class="mw-page-title-main">Plateletpheresis</span> Method of collecting platelets from blood

Plateletpheresis is the process of collecting thrombocytes, more commonly called platelets, a component of blood involved in blood clotting. The term specifically refers to the method of collecting the platelets, which is performed by a device used in blood donation that separates the platelets and returns other portions of the blood to the donor. Platelet transfusion can be a life-saving procedure in preventing or treating serious complications from bleeding and hemorrhage in patients who have disorders manifesting as thrombocytopenia or platelet dysfunction. This process may also be used therapeutically to treat disorders resulting in extraordinarily high platelet counts such as essential thrombocytosis.

<span class="mw-page-title-main">Canadian Blood Services</span>

Canadian Blood Services is a non-profit charitable organization that is independent from the Canadian government. The Canadian Blood Services was established as Canada's blood authority in all provinces and territories except for Quebec in 1998. The federal, provincial and territorial governments created the Canadian Blood Services through a memorandum of understanding. Canadian Blood Services is funded mainly through the provincial and territorial governments.

<span class="mw-page-title-main">Royal Commission of Inquiry on the Blood System in Canada</span> Royal commission of inquiry into the tainted blood scandal in Canada

The tainted blood disaster, or the tainted blood scandal, was a Canadian public health crisis in the 1980s in which thousands of people were exposed to HIV and hepatitis C through contaminated blood products. It became apparent that inadequately-screened blood, often coming from high-risk populations, was entering the system through blood transfusions. It is now considered to be the largest single (preventable) public health disaster in the history of Canada.

<span class="mw-page-title-main">Fresh frozen plasma</span> Liquid portion of whole blood

Fresh frozen plasma (FFP) is a blood product made from the liquid portion of whole blood. It is used to treat conditions in which there are low blood clotting factors or low levels of other blood proteins. It may also be used as the replacement fluid in plasma exchange. Using ABO compatible plasma, while not required, may be recommended. Use as a volume expander is not recommended. It is administered by slow injection into a vein.

Rho(D) immune globulin (RhIG) is a medication used to prevent RhD isoimmunization in mothers who are RhD negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when RhD-negative people are given RhD-positive blood. It is given by injection into muscle or a vein. A single dose lasts 12 weeks. It is made from human blood plasma.

The Irish Blood Transfusion Service (IBTS), or Seirbhís Fuilaistriúcháin na hÉireann in Irish, was established in Ireland as the Blood Transfusion Service Board (BTSB) by the Blood Transfusion Service Board (Establishment) Order, 1965. It took its current name in April 2000 by Statutory Instrument issued by the Minister for Health and Children to whom it is responsible. The Service provides blood and blood products for humans.

<span class="mw-page-title-main">Héma-Québec</span>

Héma-Québec is a non-profit organization that supplies blood and other biological products of human origin to hospitals for the Canadian province of Quebec. The organization's headquarters is located in the Montreal borough of Saint-Laurent, Quebec, and it was created on March 26, 1998, as a successor to the Canadian Red Cross Blood Program and the Canadian Blood Agency on recommendation of the Krever Commission.

NHS Blood and Transplant is an executive non-departmental public body of the United Kingdom's Department of Health and Social Care. It was established on 1 October 2005 to take over the responsibilities of two separate NHS agencies: UK Transplant, founded by Dr. Geoffrey Tovey in 1972, and the National Blood Service. Its remit is to provide a reliable, efficient supply of blood, organs and associated services to the NHS. Since NHSBT was established, the organisation has maintained or improved the quality of the services delivered to patients, stabilised the rising cost of blood, and centralised a number of corporate services.

Contaminated hemophilia blood products were a serious public health problem in the late 1970s up to 1985.

William Gary Whatcott, known as Bill Whatcott, is a Canadian social conservative activist who campaigns against homosexuality and abortion. The dramatic nature of his activities have attracted attention from the media, including an appearance on The Daily Show. He has also run for political office in Toronto, Saskatchewan and Edmonton.

<span class="mw-page-title-main">World Blood Donor Day</span> International observance, June 14

World Blood Donor Day (WBDD) is held on June 14 each year. The event was organised for the first time in 2004, by four core international organizations: the World Health Organization, the International Federation of Red Cross and Red Crescent Societies; the International Federation of Blood Donor Organizations (IFBDO) and the International Society of Blood Transfusion (ISBT) to raise awareness of the need for safe blood and blood products, and to thank blood donors for their voluntary, life-saving gifts of blood. World Blood Donor Day is one of 11 official global public health campaigns marked by the World Health Organization (WHO), along with World Health Day, World Chagas Disease Day, World Tuberculosis Day, World Immunization Week, World Patient Safety Day, World Malaria Day, World No Tobacco Day, World Hepatitis Day, World Antimicrobial Awareness Week and World AIDS Day.

<span class="mw-page-title-main">Contaminated blood scandal in the United Kingdom</span> The historical contamination of blood products in the UK with HIV and hepatitis C virus

In the 1970s and 1980s, a large number of people – most of whom had haemophilia – were infected with hepatitis C and HIV, the virus that leads to acquired immune deficiency syndrome (AIDS), as a result of receiving contaminated clotting factor products. In the United Kingdom, these were supplied by the National Health Service (NHS) and many of the products were imported from the US.

Immunoglobulin therapy is the use of a mixture of antibodies to treat several health conditions. These conditions include primary immunodeficiency, immune thrombocytopenic purpura, chronic inflammatory demyelinating polyneuropathy, Kawasaki disease, certain cases of HIV/AIDS and measles, Guillain-Barré syndrome, and certain other infections when a more specific immunoglobulin is not available. Depending on the formulation it can be given by injection into muscle, a vein, or under the skin. The effects last a few weeks.

The Trillium Gift of Life Network was an agency of the Government of Ontario responsible for the province's organ donation strategy, promotion, and supply. Ronnie Gavsie was the President & CEO. The agency maintained the popular BeADonor.ca website. It was subsequently subsumed under Ontario Health in 2019.

<span class="mw-page-title-main">Amira Abdelrasoul</span> Canadian researcher and professor

Amira Abdelrasoul is a researcher and associate professor at the Department of Chemical and Biological Engineering at the University of Saskatchewan, where she is the principal investigator of the Hemodialysis Membrane Science and Nanotechnology Research Centre. She is also a membrane technology leader in Canada, and her interdisciplinary research program focuses on solving existing hemodialysis system problems.

References

  1. Payment for blood donors comes to Canada - Health - CBC News
  2. "Donor Compensation". Donating Plasma. Retrieved 2016-03-11.
  3. Should we pay for blood? The prospect of a for-profit plasma enterprise tests the Canadian system-MACLEAN'S
  4. Payment for plasma raises ethical issues, Canadian Medical Association Journal, CMAJ, September 2, 2014, 186(12)
  5. Canadians, health professionals divided on paid plasma donations - Health - Canada.com
  6. A letter from Minister Matthews to the Government of Canada
  7. Paid plasma donors debated in roundtable - Health & Wellness - Toronto Star
  8. Round Table Discussion on Payment of Plasma Donors in Canada - Summary Report - Health Canada
  9. Province moves to halt pay-for-plasma clinics - The Spec
  10. Ontario pulls the plug on private blood clinics - News - Toronto Star
  11. Prohibiting pay-for-plasma would harm patients - Commentary - Toronto Star
  12. Durhane Wong-Rieger: The case for paid plasma donations - Full Comment - National Post [ permanent dead link ]
  13. The Canadian Hemophilia Society (CHS) policy on paid plasma donation - The Canadian Hemophilia Society (CHS)]
  14. "Voluntary Blood Donations Act, 2014, S.O. 2014, c. 14, Sched. 1". Ontario.ca. 2014-12-11. Retrieved 2016-03-11.
  15. Plasma company takes $400 million expansion out of Ontario - Queen's Park - Toronto Star
  16. "Canadian Plasma Resources' Opening Soon in the Province – Swift Current Online". Archived from the original on 2016-03-06. Retrieved 2016-03-05.
  17. Canadian plasma clinic that pays donors $25 per visit opens in Saskatoon – CBC News Saskatoon
  18. Moncton’s pay-for-plasma clinic opens, aims for 1,000 weekly donors - Toronto Star
  19. Expert Panel on Immune Globulin Product Supply and Related Impacts in Canada - Health Canada
  20. Final report of the Expert Panel on Immune Globulin Product Supply and Related Impacts in Canada - Health Canada
  21. Current Members - PPTA
  22. "Archived - Harper Government Adopts New Blood Regulations - Rules further strengthen the safety of Canada's blood supply - Canada News Centre". News.gc.ca. 2013-10-23. Retrieved 2016-03-11.